Lai-Xi Wang
Inventor
Stats
- 12 US patents issued
- 30 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 12 US Patents Issued
- 30 US Applications Filed
- 153 Total Citation Count
- Jun 25, 2024 Most Recent Filing
- Jun 20, 2003 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 1
| 2012
|
UNIVERSITY OF MARYLAND, BALTIMORE | 2
1 3 4 1 2 2 6 3 2 2 | 2003
2004 2005 2006 2007 2010 2012 2013 2014 2015 2016 |
UNIVERSITY OF MARYLAND BALTIMORE, OFFICE OF COMMERICAL VENTURES AND INTELLECTUAL PROPERTY | 2
| 2007
|
UNIVERSITY OF WASHINGTON | 1
| 2012
|
Inventor Addresses
Address | Duration |
---|---|
ELLICOTT CITY, MD, US | Sep 06, 12 - Mar 04, 21 |
Ellicott City, MD | Jul 21, 05 - Jun 12, 08 |
Ellicott City, MD, US | Apr 28, 09 - Nov 12, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 25 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 7 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12139509 | 2024 | Fc glycan remodeling platform method for site-specific antibody conjugation and applications thereof | 0 |
2024/0335,553 | 2024 | Fc GLYCAN REMODELING PLATFORM METHOD FOR SITE-SPECIFIC ANTIBODY CONJUGATION AND APPLICATIONS THEREOF | 0 |
2024/0218,342 | 2024 | SITE-SPECIFIC GLYCAN REMODELING OF LYSOSOMAL ENZYMES AND APPLICATIONS THEREOF | 0 |
11845970 | 2023 | Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins | 0 |
2023/0348,947 | 2023 | ENDO-S2 MUTANTS AS GLYCOSYNTHASES, METHOD OF MAKING AND USE FOR GLYCOENGINEERING OF GLYCOPROTEINS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.